Brief: Sun Pharma Advanced Research Receives FDA Priority Review Voucher For Sezaby Approval
Feb 3 (Reuters) - Sun Pharma Advanced Research Co Ltd SPRC.NS: SPARC RECEIVES FDA PRIORITY REVIEW VOUCHER FOR SEZABY APPROVAL INTENDS TO UTILIZE VOUCHER TO FURTHER ACCELERATE ITS PIPELINE Source text: ID:nBSEbNGrYK Further company coverage: SPRC.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees